A detailed history of American Alpha Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, American Alpha Advisors, LLC holds 9,519 shares of BMY stock, worth $445,584. This represents 0.3% of its overall portfolio holdings.

Number of Shares
9,519
Previous 9,478 0.43%
Holding current value
$445,584
Previous $439 Million 2.15%
% of portfolio
0.3%
Previous 0.34%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 29, 2025

BUY
$43.31 - $48.98 $1,775 - $2,008
41 Added 0.43%
9,519 $429 Million
Q2 2025

Aug 07, 2025

BUY
$44.12 - $59.6 $45,134 - $60,970
1,023 Added 12.1%
9,478 $439 Million
Q1 2025

May 12, 2025

SELL
$53.9 - $63.11 $35,897 - $42,031
-666 Reduced 7.3%
8,455 $516 Million
Q4 2024

Feb 11, 2025

SELL
$51.92 - $59.94 $31,100 - $35,904
-599 Reduced 6.16%
9,121 $516 Million
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $385,495 - $503,010
9,720 New
9,720 $503 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track American Alpha Advisors, LLC Portfolio

Follow American Alpha Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Alpha Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on American Alpha Advisors, LLC with notifications on news.